WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM

Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.

Sex hormones used only in the treatment of cancer (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.

The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval.


G03C ESTROGENS

This group comprises estrogens and combinations, except combinations with
- androgens, see G03E
- progestogens, see G03F
- antiandrogens, see G03HB

Hormonal contraceptives, see G03A.


Estrogens used only in neoplastic diseases, see L - Antineoplastic and immunomodulating agents.

The DDDs are based on systemic use in postmenopausal estrogen substitution therapy and in the treatment of premenstrual ailments. However, for some preparations for vaginal administration the DDDs are based on local treatment.

The DDDs for transdermal preparations are based on the amount of active ingredient delivered per 24 hours and the number of days each patch is used.


G03CC Estrogens, combinations with other drugs

This group includes combined preparations with natural, semisynthetic or synthetic estrogens and other drugs.


    ATC code  Name  DDD  U Adm.R Note
    G03CC02 dienestrol    

List of abbreviations

Last updated: 2018-12-13